The Usage of High-resolution Magnetic Resonance Imaging in Patients With Disorders of Consciousness for Early Diagnosis
- Conditions
- High-resolution Magnetic Resonance Imaging; Disorders of Consciousness
- Registration Number
- NCT03475511
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Brief Summary
In this study, high-resolution brain functional magnetic resonance imaging (MRI) was used to evaluate the differences in brain structure and brain function network between patients with different degrees of disturbance of cognition and healthy controls by means of cohort follow-up and control study. The changes of patients' The dynamic changes of learning, to explore its clinical value as an early diagnosis. Combined with neurobehavioral scales and high-resolution brain structure, functional magnetic resonance imaging data to assess the brain structure, functional characteristics and consciousness of patients with impaired consciousness, and initially establish awareness of patients with recovery of consciousness Predictable imaging signs. Twenty eligible controls, 20 VS patients, and 20 MCS patients will be considered for inclusion in the inclusion / exclusion criteria. Informed consent will be obtained as required before starting any registration process.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
(1) no use of centrally acting drugs, (2) no use of neuromuscular function blockers and no sedation within the prior 24 h, (3) periods of eye opening indicating a preserved sleep-wake cycle, and (4) a diagnosis of VS or MCS established according to internationally established criteria
Magnetic resonance contraindications
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diffusion magnetic resonance imaging analysis Three months The color-coding of tractography pathways in was determined for a visualization purpose. The color-coding of tractography pathways was based on FA values.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hangzhou Hospital of Zhejiang CAPR
🇨🇳Hangzhou, Zhejiang, China